Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by regardlesson Jan 19, 2021 1:19pm
312 Views
Post# 32327372

safe to say this

safe to say this-i highly doubt a financing is comming so craighenry and i ruled that out this morning so this has to be somthing else..

-reasons for not having a financing are that bioasis wouldnt do one for 4-5 million when they have 4 million in cash on hand from chiesi.they wouldnt do a big one for say 30million dollars to go to the clinic alone because they have changed to a partnership model and that would triple our float so thats not happening either...

- state side volume is climbing and we still have almost three hours of trading left, i could see this closing t 70 cents with 1 million in volume across all exchanges and that would lead me to belive that accumilation is occuring because of anticipation or expectation of somegreat materialistacally soon
<< Previous
Bullboard Posts
Next >>